Acticor Biotech SA
PAR:ALACT
Balance Sheet
Balance Sheet Decomposition
Acticor Biotech SA
Current Assets | 13m |
Cash & Short-Term Investments | 8m |
Receivables | 4.4m |
Other Current Assets | 656k |
Non-Current Assets | 1.3m |
Long-Term Investments | 436k |
PP&E | 28k |
Intangibles | 713k |
Other Non-Current Assets | 86k |
Current Liabilities | 8.6m |
Accounts Payable | 5.3m |
Short-Term Debt | 1.9m |
Other Current Liabilities | 1.4m |
Non-Current Liabilities | 5.3m |
Long-Term Debt | 4.3m |
Other Non-Current Liabilities | 986k |
Balance Sheet
Acticor Biotech SA
Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
1
|
3
|
2
|
3
|
2
|
1
|
13
|
8
|
11
|
7
|
|
Cash |
1
|
3
|
2
|
3
|
2
|
1
|
13
|
8
|
11
|
7
|
|
Short-Term Investments |
4
|
6
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
10
|
7
|
9
|
7
|
4
|
2
|
1
|
2
|
4
|
5
|
|
Accounts Receivables |
8
|
5
|
6
|
6
|
3
|
1
|
1
|
1
|
1
|
1
|
|
Other Receivables |
2
|
2
|
3
|
1
|
1
|
1
|
1
|
1
|
4
|
4
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
|
Total Current Assets |
16
|
17
|
13
|
12
|
7
|
4
|
14
|
10
|
17
|
12
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Intangible Assets |
11
|
9
|
11
|
8
|
6
|
3
|
1
|
1
|
1
|
1
|
|
Goodwill |
6
|
5
|
5
|
9
|
2
|
1
|
0
|
0
|
0
|
0
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
6
|
5
|
5
|
9
|
2
|
1
|
0
|
0
|
0
|
0
|
|
Total Assets |
33
N/A
|
31
-5%
|
30
-4%
|
29
-5%
|
16
-45%
|
9
-45%
|
15
+80%
|
11
-28%
|
18
+62%
|
13
-28%
|
|
Liabilities | |||||||||||
Accounts Payable |
6
|
6
|
6
|
6
|
5
|
4
|
2
|
3
|
3
|
5
|
|
Accrued Liabilities |
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Other Current Liabilities |
4
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
1
|
1
|
|
Total Current Liabilities |
12
|
9
|
9
|
9
|
6
|
5
|
5
|
6
|
4
|
7
|
|
Long-Term Debt |
1
|
4
|
4
|
3
|
3
|
3
|
1
|
2
|
2
|
7
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Total Liabilities |
13
N/A
|
13
-4%
|
13
+0%
|
12
-8%
|
9
-21%
|
8
-14%
|
6
-21%
|
9
+46%
|
7
-26%
|
15
+121%
|
|
Equity | |||||||||||
Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
|
Retained Earnings |
6
|
5
|
4
|
3
|
7
|
13
|
19
|
10
|
13
|
26
|
|
Additional Paid In Capital |
13
|
13
|
13
|
13
|
13
|
13
|
27
|
12
|
23
|
23
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
19
N/A
|
18
-5%
|
17
-7%
|
17
-3%
|
6
-62%
|
0
-93%
|
9
+1 826%
|
2
-81%
|
11
+542%
|
2
N/A
|
|
Total Liabilities & Equity |
33
N/A
|
31
-5%
|
30
-4%
|
29
-5%
|
16
-45%
|
9
-45%
|
15
+80%
|
11
-28%
|
18
+62%
|
13
-28%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
3
|
3
|
3
|
3
|
3
|
3
|
11
|
11
|
11
|
11
|